InsidersTradesSigma
Follow the Cutia Therapeutics - B stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Market capitalisation: €710.4m. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: Zhang Lele. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Cutia Therapeutics - B es una empresa centrada en el desarrollo de tratamientos innovadores para enfermedades crónicas. Se especializa en la investigación y el avance de soluciones terapéuticas.